Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

Grant Application Deadline Extended to November 15th for Researchers Investigating Causes/Treatments of Job Syndrome

Job Research Foundation
Posted on: 26 Sep 18
Grant Application Deadline Extended to November 15th for Researchers Investigating Causes/Treatments of Job Syndrome Job Research Foundation will award a pair of two-year grants of up to $200,000 each, and a pair of two-year grants of up to $50,000 each to qualified grantees for research into the causes and treatments of the rare multisystem immunodeficiency disorder called Job Syndrome; and the deadline has been extended to November 15, 2018 and grants will be awarded on December 17th.

PR Newswire

NEW YORK, Sept. 26, 2018

NEW YORK, Sept. 26, 2018 /PRNewswire-PRWeb/ -- The Job Research Foundation has announced that it will extend the deadline for its grant application to November 15th, 2018. Job Research Foundation will award a pair of two-year grants of up to $200,000 each, and a pair of two-year grants of up to $50,000 each to qualified grantees for research into the causes and treatments of the rare multisystem immunodeficiency disorder called Job Syndrome. Special consideration will be given to research focused on Job Syndrome and Pulmonary Function. The application process is open to researchers world-wide through November 15th, 2018 and grants will be awarded by December 17th, 2018.

The Job Research Foundation seeks to not only help find a cure for Job Syndrome by providing the scientific community with additional opportunities to further research into the rare multisystem immunodeficiency disorder, but also hopes that investigators will research treatments for those suffering with Job Syndrome.

Only about 300 cases of Job's Syndrome have been reported since it was first discovered. Patients often suffer from life-threatening complications from basic infections as the disease makes the immune system extremely sensitive to bacteria. People with the syndrome often have multiple, recurring ailments, such as skin infections that cause lesions and boils, and lung infections that cause pneumonia. The disease was named after the Biblical character Job who suffered from boils.

"Our long-term goal is to help advance research to find a cure for Job Syndrome and after several requests we felt it was prudent to extend the deadline to give researchers around the world ample time to submit their application," said Ted Lavin, co-founder of The Job Research Foundation. "In the short term, we hope the research will improve the treatments for patients suffering from this rare disease."

Job Syndrome, also known as Autosomal Dominant Hyperimmunoglobulin E Syndrome (AD-HIES), was discovered in 1966 and is a multisystem immunodeficiency disorder found in males and females worldwide. It can be inherited from either parent or result from a new genetic mutation.

Visit https://www.jobresearchfoundation.org/ for additional details about The Job Syndrome Foundation and for information about the Grant Application Process. Job Research Foundation is located at 459 Columbus Avenue in New York. Send emails to info@jobresearchfoundation.org.

 

SOURCE Job Research Foundation

PR Newswire
www.prnewswire.com

Last updated on: 26/09/2018

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.